Literature DB >> 7594353

Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori.

M Suzuki1, M Nakamura, M Mori, S Miura, M Tsuchiya, H Ishii.   

Abstract

We studied the influence of lansoprazole on Helicobacter pylori-elicited neutrophil activation, including the oxidative burst and infiltration of gastric mucosa, and confirmed whether radiolabeled lansoprazole is actually detected in gastric neutrophils. The oxidative burst of purified human neutrophils was measured by luminol-dependent chemiluminescence (ChL). [3H]Lansoprazole uptake sites in human gastric mucosa were observed by autoradiography. The magnitude of neutrophil infiltration of gastric mucosa was assessed by tissue myeloperoxidase (MPO) content. ChL assay indicated that oxygen-derived free radical production was increased twofold by adding H. pylori water extract, which was significantly inhibited by lansoprazole (10(-4) M). Gastric biopsy samples were obtained endoscopically from patients with H. pylori-positive gastritis. Autoradiographic examination revealed that the [3H]lansoprazole binding site was present in the cytoplasmic granules of infiltrated neutrophils. Tissue MPO content was significantly decreased after treatment with lansoprazole. These data suggest that lansoprazole binds directly to neutrophils, subsequently inhibiting neutrophil accumulation and release of toxic metabolites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594353     DOI: 10.1097/00004836-199506002-00025

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  23 in total

1.  Mechanical manipulation of polymorphonuclear leukocyte plasma membranes with optical tweezers causes influx of extracellular calcium through membrane channels.

Authors:  A Holm; T Sundqvist; A Oberg; K E Magnusson
Journal:  Med Biol Eng Comput       Date:  1999-05       Impact factor: 2.602

2.  Myeloperoxidase, xanthine oxidase and superoxide dismutase in the gastric mucosa of Helicobacter pylori positive and negative pediatric patients.

Authors:  Mustafa Akcam; Oguz Elmas; Aygen Yilmaz; Serkan Cağlar; Reha Artan; Tekinalp Gelen; Yakup Alicigüzel
Journal:  Mol Cell Biochem       Date:  2006-06-07       Impact factor: 3.396

3.  Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.

Authors:  Corrado Blandizzi; Matteo Fornai; Rocchina Colucci; Gianfranco Natale; Valter Lubrano; Cristina Vassalle; Luca Antonioli; Gloria Lazzeri; Mario Del Tacca
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

4.  Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.

Authors:  M Fornai; G Natale; R Colucci; M Tuccori; G Carazzina; L Antonioli; S Baldi; V Lubrano; A Abramo; C Blandizzi; M Del Tacca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-04       Impact factor: 3.000

5.  Suppression of proinflammatory cytokine production in macrophages by lansoprazole.

Authors:  Akinari Hinoki; Kazunori Yoshimura; Keiko Fujita; Masumi Akita; Rie Ikeda; Masabumi Nagashima; Masahiko Nomura; Akira Satomi
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

6.  Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.

Authors:  C Blandizzi; G Natale; G Gherardi; G Lazzeri; C Marveggio; R Colucci; D Carignani; M Del Tacca
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

7.  Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells.

Authors:  T Ohara; T Arakawa
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

8.  Fluconazole attenuates lung injury and mortality in a rat peritonitis model.

Authors:  Mohammad Tariq; Ahmed Al Moutaery; Mohammed Arshaduddin; Haseeb Ahmad Khan; David Price Evans; Sydney Jacobs
Journal:  Intensive Care Med       Date:  2003-09-27       Impact factor: 17.440

9.  Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor-alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated Kinase.

Authors:  Tetsuya Tanigawa; Toshio Watanabe; Kazuhide Higuchi; Hirohisa Machida; Hirotoshi Okazaki; Hirokazu Yamagami; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

Review 10.  Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.

Authors:  Ramalinga R Kedika; Rhonda F Souza; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.